|
[1]
|
中华人民共和国国家卫生健康委员会办公厅, 中华人民共和国国家中医药管理局综合司. 新型冠状病毒感染诊疗方案(试行第十版) [J]. 中国医药, 2023, 18(2): 161-166.
|
|
[2]
|
中华医学会呼吸病学分会慢性阻塞性肺疾病学组, 中国医师协会呼吸医师分会慢性阻塞性肺疾病工作委员会. 慢性阻塞性肺疾病诊治指南(2021年修订版) [J]. 中华结核和呼吸杂志, 2021, 44(3): 170-205.
|
|
[3]
|
Kózka, M., Sega, A., Wojnar-Gruszka, K., Tarnawska, A. and Gniadek, A. (2020) Risk Factors of Pneumonia Associated with Mechanical Ventilation. International Journal of Environmental Research and Public Health, 17, Article 656. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Johns, M., George, S., Taburyanskaya, M. and Poon, Y.K. (2021) A Review of the Evidence for Corticosteroids in Covid-19. Journal of Pharmacy Practice, 35, 626-637. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
de Lusignan, S., Dorward, J., Correa, A., Jones, N., Akinyemi, O., Amirthalingam, G., et al. (2020) Risk Factors for SARS-CoV-2 among Patients in the Oxford Royal College of General Practitioners Research and Surveillance Centre Primary Care Network: A Cross-Sectional Study. The Lancet Infectious Diseases, 20, 1034-1042. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Kew, K.M. and Seniukovich, A. (2014) Inhaled Steroids and Risk of Pneumonia for Chronic Obstructive Pulmonary Disease. Cochrane Database of Systematic Reviews, No. 3, CD010115. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Aveyard, P., Gao, M., Lindson, N., Hartmann-Boyce, J., Watkinson, P., Young, D., et al. (2021) Association between Pre-Existing Respiratory Disease and Its Treatment, and Severe COVID-19: A Population Cohort Study. The Lancet Respiratory Medicine, 9, 909-923. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Choi, J.C., Jung, S., Yoon, U.A., You, S., Kim, M., Baek, M.S., et al. (2020) Inhaled Corticosteroids and COVID-19 Risk and Mortality: A Nationwide Cohort Study. Journal of Clinical Medicine, 9, Article 3406. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Halpin, D.M.G., Criner, G.J., Papi, A., Singh, D., Anzueto, A., Martinez, F.J., et al. (2021) Global Initiative for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease. The 2020 GOLD Science Committee Report on COVID-19 and Chronic Obstructive Pulmonary Disease. American Journal of Respiratory and Critical Care Medicine, 203, 24-36. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
National Institute for Health and Care Excellence (NICE) (2020) COVID-19 Rapid Guideline: Community-Based Care of Patients with Chronic Obstructive Pulmonary Disease (COPD). National Institute for Health and Care Excellence: Clinical Guidelines.
|
|
[11]
|
Sen, P., Majumdar, U., Zein, J., Hatipoğlu, U. and Attaway, A.H. (2021) Inhaled Corticosteroids Do Not Adversely Impact Outcomes in COVID-19 Positive Patients with COPD: An Analysis of Cleveland Clinic’s COVID-19 Registry. PLOS ONE, 16, e0252576. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Furci, F., Caminati, M., Senna, G. and Gangemi, S. (2021) The Potential Protective Role of Corticosteroid Therapy in Patients with Asthma and COPD against Covid-19. Clinical and Molecular Allergy, 19, Article No. 19. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Halpin, D.M.G., Singh, D. and Hadfield, R.M. (2020) Inhaled Corticosteroids and COVID-19: A Systematic Review and Clinical Perspective. European Respiratory Journal, 55, Article ID: 2001009. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
The RECOVERY Collaborative Group (2021) Dexamethasone in Hospitalized Patients with Covid-19. New England Journal of Medicine, 384, 693-704. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
Griesel, M., Wagner, C., Mikolajewska, A., Stegemann, M., Fichtner, F., Metzendorf, M., et al. (2022) Inhaled Corticosteroids for the Treatment of Covid-19. Cochrane Database of Systematic Reviews, 3, CD015125. [Google Scholar] [CrossRef] [PubMed]
|
|
[16]
|
陈琼, 余维巍, 王丽静, 等. 老年人新型冠状病毒肺炎防治要点(试行) [J]. 中华老年医学杂志, 2020, 39(2): 113-118.
|
|
[17]
|
张法. 联合吸入激素与长效β_2激动剂治疗慢性阻塞性肺疾病稳定期的临床观察[J]. 中国当代医药, 2010, 17(34): 28-29.
|
|
[18]
|
包金英. 慢性阻塞性肺疾病急性加重期应用全身性糖皮质激素的效果分析[J]. 中国实用医药, 2021, 16(36): 159-162.
|
|
[19]
|
Woods, J.A., Wheeler, J., Finch, C. and Pinner, N. (2014) Corticosteroids in the Treatment of Acute Exacerbations of Chronic Obstructive Pulmonary Disease. International Journal of Chronic Obstructive Pulmonary Disease, 9, 421-430. [Google Scholar] [CrossRef] [PubMed]
|
|
[20]
|
Rice, J.B., White, A.G., Scarpati, L.M., Wan, G. and Nelson, W.W. (2017) Long-Term Systemic Corticosteroid Exposure: A Systematic Literature Review. Clinical Therapeutics, 39, 2216-2229. [Google Scholar] [CrossRef] [PubMed]
|
|
[21]
|
Leuppi, J.D., Schuetz, P., Bingisser, R., Bodmer, M., Briel, M., Drescher, T., et al. (2013) Short-Term vs Conventional Glucocorticoid Therapy in Acute Exacerbations of Chronic Obstructive Pulmonary Disease. JAMA, 309, 2223-2231. [Google Scholar] [CrossRef] [PubMed]
|
|
[22]
|
de Jong, Y.P., Uil, S.M., Grotjohan, H.P., Postma, D.S., Kerstjens, H.A.M. and van den Berg, J.W.K. (2007) Oral or IV Prednisolone in the Treatment of COPD Exacerbations. Chest, 132, 1741-1747. [Google Scholar] [CrossRef] [PubMed]
|
|
[23]
|
Walters, J.A., Tan, D.J., White, C.J. and Wood-Baker, R. (2018) Different Durations of Corticosteroid Therapy for Exacerbations of Chronic Obstructive Pulmonary Disease. Cochrane Database of Systematic Reviews, 3, CD006897. [Google Scholar] [CrossRef] [PubMed]
|
|
[24]
|
Li, L., Zhao, N., Ma, X., Sun, F., He, B., Qin, Z., et al. (2021) Personalized Variable vs Fixed-Dose Systemic Corticosteroid Therapy in Hospitalized Patients with Acute Exacerbations of COPD. Chest, 160, 1660-1669. [Google Scholar] [CrossRef] [PubMed]
|
|
[25]
|
Finch, D., Pavord, I., Jones, P., Burgel, P.R. and Rabe, K.F. (2016) Exacerbations of COPD. International Journal of Chronic Obstructive Pulmonary Disease, 11, 21-30. [Google Scholar] [CrossRef] [PubMed]
|
|
[26]
|
UK, N.C.G.C. (2010) Chronic Obstructive Pulmonary Disease: Management of Chronic Obstructive Pulmonary Disease in Adults in Primary and Secondary Care. National Institute for Health and Clinical Excellence: Guidance. Royal College of Physicians (UK).
|
|
[27]
|
Bafadhel, M., McKenna, S., Terry, S., Mistry, V., Reid, C., Haldar, P., et al. (2011) Acute Exacerbations of Chronic Obstructive Pulmonary Disease. American Journal of Respiratory and Critical Care Medicine, 184, 662-671. [Google Scholar] [CrossRef] [PubMed]
|
|
[28]
|
Bafadhel, M., McKenna, S., Terry, S., Mistry, V., Pancholi, M., Venge, P., et al. (2012) Blood Eosinophils to Direct Corticosteroid Treatment of Exacerbations of Chronic Obstructive Pulmonary Disease. American Journal of Respiratory and Critical Care Medicine, 186, 48-55. [Google Scholar] [CrossRef] [PubMed]
|
|
[29]
|
World Health Organization (2020) Clinical Management of Severe Acute Respiratory Infection (SARI) When COVID-19 Disease Is Suspected. Interim Guidance. Pediatria i Medycyna Rodzinna, 16, 9-26. [Google Scholar] [CrossRef]
|
|
[30]
|
Hasan, S.S., Capstick, T., Zaidi, S.T.R., Kow, C.S. and Merchant, H.A. (2020) Use of Corticosteroids in Asthma and COPD Patients with or without Covid-19. Respiratory Medicine, 170, Article ID: 106045. [Google Scholar] [CrossRef] [PubMed]
|
|
[31]
|
诊治专家组慢性阻塞性肺疾病急性加重AECOPD. 慢性阻塞性肺疾病急性加重(AECOPD)诊治中国专家共识(2017年更新版) [J]. 国际呼吸杂志, 2017, 37(14): 1041-1057.
|